Healthcare provider profile · identity verified

Andrew Gordon, M.D.

Internal Medicine · TULSA, OK · NPI 1447228549

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	490	154
Amlodipine Besylate	Amlodipine Besylate	407	120
Levothyroxine Sodium	Levothyroxine Sodium	389	110
Lisinopril	Lisinopril	341	101
Tramadol Hcl	Tramadol Hcl	339	80
Gabapentin	Gabapentin	272	63
Metformin Hcl	Metformin Hcl	267	78
Omeprazole	Omeprazole	267	78
Losartan Potassium	Losartan Potassium	266	80
Pantoprazole Sodium	Pantoprazole Sodium	247	67
Metoprolol Succinate	Metoprolol Succinate	214	63
Rosuvastatin Calcium	Rosuvastatin Calcium	213	73
Albuterol Sulfate Hfa	Albuterol Sulfate	180	57
Metoprolol Tartrate	Metoprolol Tartrate	177	58
Meloxicam	Meloxicam	175	51
Furosemide	Furosemide	174	56
Hydrochlorothiazide	Hydrochlorothiazide	165	60
Tamsulosin Hcl	Tamsulosin Hcl	165	46
Zolpidem Tartrate	Zolpidem Tartrate	149	33
Trazodone Hcl	Trazodone Hcl	142	38
Fluticasone Propionate	Fluticasone Propionate	134	41
Potassium Chloride	Potassium Chloride	134	33
Fluoxetine Hcl	Fluoxetine Hcl	123	32
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	122	46
Allopurinol	Allopurinol	121	31
Glimepiride	Glimepiride	112	39
Methylprednisolone	Methylprednisolone	110	98
Sertraline Hcl	Sertraline Hcl	105	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	103	36
Trulicity	Dulaglutide	101	17
Carvedilol	Carvedilol	98	33
Simvastatin	Simvastatin	98	24
Lovastatin	Lovastatin	97	23
Eliquis	Apixaban	95	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	94	27
Prednisone	Prednisone	87	61
Celecoxib	Celecoxib	86	28
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	81	25
Metformin Hcl Er	Metformin Hcl	81	24
Montelukast Sodium	Montelukast Sodium	81	27
Pioglitazone Hcl	Pioglitazone Hcl	78	24
Venlafaxine Hcl Er	Venlafaxine Hcl	77	15
Atenolol	Atenolol	73	21
Pravastatin Sodium	Pravastatin Sodium	72	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	71	49
Azithromycin	Azithromycin	69	65
Duloxetine Hcl	Duloxetine Hcl	67	16
Olmesartan Medoxomil	Olmesartan Medoxomil	64	24
Ondansetron Odt	Ondansetron	64	25
Clopidogrel	Clopidogrel Bisulfate	63	21
Famotidine	Famotidine	63	23
Ozempic	Semaglutide	62	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	62	11
Donepezil Hcl	Donepezil Hcl	59	13
Ropinirole Hcl	Ropinirole Hcl	56	12
Glipizide	Glipizide	54	16
Spironolactone	Spironolactone	54	19
Citalopram Hbr	Citalopram Hydrobromide	53	15
Warfarin Sodium	Warfarin Sodium	52	17
Hydralazine Hcl	Hydralazine Hcl	50	11
Diclofenac Sodium	Diclofenac Sodium	49	15
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	49	17
Escitalopram Oxalate	Escitalopram Oxalate	47	18
Xarelto	Rivaroxaban	47	12
Buspirone Hcl	Buspirone Hcl	44	suppressed
Pregabalin	Pregabalin	44	suppressed
Nystatin	Nystatin	42	15
Finasteride	Finasteride	41	14
Fluconazole	Fluconazole	41	23
Alendronate Sodium	Alendronate Sodium	38	13
Baclofen	Baclofen	38	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	37	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Tizanidine Hcl	Tizanidine Hcl	36	11
Alprazolam	Alprazolam	35	12
Bupropion Xl	Bupropion Hcl	35	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	35	31
Testosterone Cypionate	Testosterone Cypionate	35	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	14
Cefdinir	Cefdinir	33	28
Mupirocin	Mupirocin	33	24
Triamcinolone Acetonide	Triamcinolone Acetonide	33	18
Lorazepam	Lorazepam	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Cephalexin	Cephalexin	31	22
Eszopiclone	Eszopiclone	31	suppressed
Risperidone	Risperidone	31	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	30	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	23
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Jardiance	Empagliflozin	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Irbesartan	Irbesartan	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Acyclovir	Acyclovir	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Torsemide	Torsemide	21	suppressed
Estradiol	Estradiol	20	12
Ibuprofen	Ibuprofen	20	suppressed
Glipizide Er	Glipizide	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	16	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Valsartan	Valsartan	15	suppressed
Clonazepam	Clonazepam	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Praluent Pen	Alirocumab	14	suppressed
Raloxifene Hcl	Raloxifene Hcl	14	suppressed
Aimovig Autoinjector	Erenumab-Aooe	13	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Digoxin	Digoxin	13	suppressed
Levofloxacin	Levofloxacin	13	12
Oxcarbazepine	Oxcarbazepine	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Primidone	Primidone	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed
Synjardy	Empagliflozin/Metformin Hcl	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error